Some structural and functional consequences of hepatic adenosine triphosphate deficiency induced by intraperitoneal D-fructose administration.
D000255:Adenosine Triphosphate / Q000378:metabolism*; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000378:metabolism; D002250:Carbon Radioisotopes; D005260:Female; D005561:Formates / Q000378:metabolism; D005632:Fructose / Q000008:administration & dosage / Q000378:metabolism / Q000633:toxicity*; D005947:Glucose / Q000008:administration & dosage; D005998:Glycine / Q000378:metabolism; D007930:Leucine / Q000378:metabolism; D008099:Liver / Q000166:cytology / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D008854:Microscopy, Electron; D009963:Orotic Acid / Q000378:metabolism; D014176:Protein Biosynthesis; D012313:RNA / Q000096:biosynthesis; D051381:Rats
D000903:Antibiotics, Antineoplastic; D002250:Carbon Radioisotopes; D005561:Formates; D005632:Fructose; D009963:Orotic Acid; D012313:RNA; D000255:Adenosine Triphosphate; D007930:Leucine; D005947:Glucose; D005998:Glycine